Effectiveness of Neurodynamic Sliding Mobilisation in the "Slump" Position in Relation to the Perceptible Pain Threshold in Asymptomatic People

Launched by UNIVERSITY HOSPITAL, ROUEN · Apr 4, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating a specific treatment technique called "neurodynamic sliding mobilisation" in a position known as the "slump" position. The goal is to see how this technique can affect pain levels in people without any current back pain. Researchers believe that this method might help the body manage pain better by activating certain pathways in the nervous system. This study is important because it may provide insights into how this technique can be more effective than other methods for reducing pain.

To participate in this trial, you must be between 30 and 65 years old, and you should not have any previous experience with neurodynamic mobilisation techniques. You need to be fluent in French and provide consent to join the study. Participants will undergo assessments and treatments, and they should not have any current back or leg pain issues that would prevent them from participating. If you meet these criteria and are interested, this trial could be an opportunity to contribute to understanding new ways to manage pain.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subjects aged 30 years or older and less than 65 years;
• • Subjects considered naive to neurodynamic mobilisation techniques;
• • Volunteers who have read and understood the information letter and have given their written consent to participate in the study;
• • Fluent in spoken and read French;
• • Effective contraception in women of childbearing age (progestin-only or intrauterine device or tubal ligation) for at least 12 months;
• • For postmenopausal women, a confirmatory diagnosis must be obtained (non-drug-induced amenorrhoea for at least 12 months prior to the enrolment visit);
• • Subject affiliated to a social security scheme.
• Exclusion Criteria:
• • Positive slump test on the day of the selection visit (production of asymmetric lumbar symptoms or painful radiations in at least one lower limb or unilateral reduction in physiological knee extension range of motion compared with the contralateral side);
• • Neurological and neuropathic pain assessment score (DN4) greater than 4;
• • Increase or decrease in sensory function in the lower limb compared with the contralateral side, as measured by Clinical Sensory Testing (CST);
• • Any physical exertion of perceived intensity greater than 17 on the Borg 6-20 scale in the 72 hours prior to the trial and during the trial;
• • Injury, complaint or symptom affecting the spine (cervical, thoracic, lumbar) and/or lower limb(s) requiring absence from work, school or leisure activities in the 12 months prior to enrolment;
• • History of major surgery, injury to the trunk, spine and/or lower limb(s), or history of progressive rheumatic, neurological or oncological pathology;